Siemens Healthcare Diagnostics, Inc.: Medical Device Recall in 2024 - (Recall #: Z-1304-2024)

Updated on March 25, 2026.

See the recall detail below. You can also see other recalls from the same firm in 2024.

Data Source: FDA.
Product Description:

DCA Systems HbA1c Reagent Kit

Product Classification:

Class II

Date Initiated: February 7, 2024
Date Posted: March 27, 2024
Recall Number: Z-1304-2024
Event ID: 94021
Reason for Recall:

The reason for the recall is that the Siemens DCA HbA1c Reagent Kit was confirmed to display a positive bias without alerting the user. The potential impact of the defect is that erroneous test results could be reported and potentially lead to incorrect patient management of glucose control. A positive bias may be observed with eleven HbA1c affected lots. Positive bias was observed when the performance of these five HbA1c lots was compared to NGSP pooled patient target-value assigned samples and the maximum bias observed was 19%.

Status: Ongoing
Product Quantity: 74,211 Kits (Expanded 2/28/24: additional 72,892 kits)
Code Information:

Siemens Material Number: 10311134; UDI/DI: 00630414532806; Lot#: 9640093, 0645103, 0648103, 0649103, 0654103 . Expanded Lots (02/28/2024): 0637093, 0641093, 0642093, 0647103, 0653103, 0655103;

Distribution Pattern:

Worldwide distribution - US Nationwide and the country of Taiwan.

Voluntary or Mandated:

Voluntary: Firm initiated